(Q42977371)
Statements
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy (English)
Chen-Hua Liu
Cheng-Chao Liang
Chun-Jen Liu
Tai-Chung Tseng
Chih-Lin Lin
Sheng-Shun Yang
Shih-Jer Hsu
Jou-Wei Lin
Jun-Herng Chen
Pei-Jer Chen
Ding-Shinn Chen
20 December 2011